seminar on crystal growth and its prevention by r.tulasi m.pharmacy, ist semester department of...
TRANSCRIPT
![Page 1: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/1.jpg)
seminar on
CRYSTAL GROWTH AND ITS PREVENTION
By
R.TULASI M.Pharmacy, Ist semester
Department of pharmaceuticsUNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES
Kakatiya universityWarangal, Andhra Pradesh.
![Page 2: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/2.jpg)
CONTENTS:
INTRODUCTION
OBJECTIVE
PROCESS OF CRYSTAL GROWTH
PROCESS VARIABLES
FACTORS AFFECTING CRYSTAL GROWTH IN
DRUG FORMULATIONS
PREVENTION
CONCLUSION
REFERENCES
![Page 3: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/3.jpg)
INTRODUCTION
• CRYSTAL: A crystal is a three dimensional arrangement of atoms and crystalline solid refers to aggregates of atoms/molecules/their ions arranged in a regular repetition.
• Crystallization is a process of formation of crystals from the solvent in which the solute is dissolved.
• Crystallization is employed as the final step in the purification of a solid.
![Page 4: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/4.jpg)
A crystalline particle is characterized by definite internal and external structures.
Crystal habit: Describes the external shape of a crystal.
Polymorphic state refers to the definite arrangement of the molecules inside the crystal lattice.
Different crystal habits:
Acicular
Aggregate
Blade
Dendritic
Cubic
Fiber
Prismatic
Various indices of dosage form performance such as particle orientation, flowability, packing, compaction, suspension stability and dissolution can be altered with changes in crystal habit.
![Page 5: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/5.jpg)
OBJECTIVEThe knowledge and concept of crystal growth forms the basis for understanding the formation of crystals and various factors influencing the crystal growth.
The crystal growth studies help in
• Improving the physical stability of pharmaceutical formulations.
• Maintaining uniformity in raw material characteristics.
• Maintaining uniformity in batch to batch dosage form performance.
![Page 6: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/6.jpg)
Process of crystal growth:It involves three steps:
1. Supersaturation
2. Nucleation
3. Growth of nuclei into crystals
Supersaturation : When the solubility of a compound in a solvent exceed the saturation solubility, the solution becomes supersaturated and the compound may crystallize.
It is the basic driving force for crystallization.
Methods for supersaturation:
• By increasing solute concentration
• By decreasing solute solubility
![Page 7: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/7.jpg)
Nucleation: Nucleation refers to the birth of very small bodies of a new phase within a homogenous supersaturated liquid phase.
The initially formed solid particles are of molecular size which are termed as nuclei.
![Page 8: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/8.jpg)
Growth of nuclei into crystal
As stable nuclei form, they grow into macroscopic crystals. This portion of the crystallization process is known as “crystal growth”. This process consists of several stages through which the growth units pass.
These include the following:
Transport of the growth unit from or through the bulk solution to an
impingement site, which is not necessarily the final growth site.
Adsorption of the growth unit at the impingement site.
Diffusion of the growth units from the site of impingement to a growth site.
Incorporation into the lattice.
![Page 9: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/9.jpg)
Process variables of crystallization & their influence on dosage form performance
Supersaturation
Rate of cooling
Degree of solution agitation
Temperature
Nature of crystallizing solvent
Presence of impurities
![Page 10: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/10.jpg)
Crystal Growth in Disperse Systems
Ostwald Ripening :
The growth of large particles at the expense of smaller ones, because of a
difference in solubility rates of different size particles.
![Page 11: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/11.jpg)
This effect can be expressed by the following relationship
Where S is the initial solubility of small particles
S0 is the solubility rate of large particles at equilibrium
r is the particle radius in cm
k is a constant that includes surface tension, temperature,
molar volume and thermodynamic terms ( k=1.21×10-6 )
For example, the solubility rate of a 0.2-mm particle, is
13%. For a 2-mm particle, it is 1%, and for particles above 20 mm, it is
negligible.
![Page 12: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/12.jpg)
Factors Affecting Crystal Growth in
Drug Formulations
Particle size distribution
Dissolution and Recrystallization
Changes in pH
Temperature fluctuations
Polymorphic transformations
![Page 13: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/13.jpg)
Particle size distribution Particle size distribution of dispersed system increases during aging which
ultimately results in the crystal growth.
Drug particle size is the important factor influencing product appearance,
stability of pharmaceutical suspensions and the therapeutic effect of active
ingredients.
Dissolution and recrystallization Particle size, temperature and polymorphic transformations influence the
solubility and hence the dissolution of a drug and may cause recrystallization.
![Page 14: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/14.jpg)
Changes in pH
• The solubility of weakly acidic or basic drugs is influenced by pH.
• The changes in pH produces degree of super saturation which gives rise to
nucleation and crystal growth.
• Drug decomposition may occur because the product of decomposition
causes a shift in the pH which in turn have a marked effect on solubility.
![Page 15: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/15.jpg)
Temperature fluctuations:
Crystal growth due to temperature fluctuations during storage is of
importance especially when the suspensions are subjected to temperature cycling of
20ºC or more.
These effects depend on the magnitude of temperature change, the time
interval and the effect of temperature on the drug’s solubility and subsequent
recrystallization process.
Changes in temperature may change particle size distribution and
polymorphic form of drug. Thus resulting in the crystal growth and it also alters the
absorption rate and bioavailability.
![Page 16: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/16.jpg)
Polymorphic transformations:
Drugs may undergo a change from one metastable polymorphic form to a
more stable polymorphic form.
This leads to the formation of distinct new crystalline entities during
storage is possible.
For Ex: An originally anhydrous drug in a suspension may rapidly or
slowly form a hydrate. These various forms may exhibit different
solubilities, melting points.
![Page 17: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/17.jpg)
Need For Crystal Growth Prevention in
Drug Formulations
Suspensions and Solutions -- physical stability
Parenterals -- syringeability and injectability
Aerosols -- valve clogging and inaccuracy of dose
Opthalmic -- ocular irritation
Tablets -- prolonged disintegration, cracks, altered
appearance and altered bioavailability
![Page 18: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/18.jpg)
Crystal Growth Inhibitors
Surfactants : By Adsorption process
Anionic - Sodium lauryl sulfate, sodium dodecyl sulfate, sodium dodecyl benzene
sulphonates .
Cationic – Quaternary ammonium compounds like CTAB, TDAC, Benzylkonium
chloride, Benzathonium chloride.
Nonionics : Tweens, Spans, Carbowaxes (High molecular weight PEGs) Pluronics.
Polymers : By forming a net like film
PVP, PEGs, Poly alcohol, Poly ethylene oxide, Bovine serum albumin
Protective colloids : By creation of protective coat or
boundary layer
![Page 19: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/19.jpg)
Prevention Of Crystal Growth
Selection of particles with a narrow range of particle sizes, such as micro crystals between 1 to 10μ.
Selection of a stable crystalline drug form that usually exhibits lower aqueous solubility. The crystalline form that is physically most stable usually has the highest melting point.
High-energy milling should not be used during particle size reduction. Micro crystals are best formed by controlled precipitation techniques or
shock cooling.
![Page 20: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/20.jpg)
A water-dispersible surfactant or wetting agent dissipates the free
surface energy of particles by reducing the interfacial tension between
the solid and the suspending vehicle.
A protective colloid, such as gelatin , gum, or a cellulosic derivative, is
used to form a film barrier around the particles, inhibiting dissolution
and subsequent crystal growth.
The viscosity of the suspending vehicle is increased to retard particle
dissolution and subsequent crystal growth.
![Page 21: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/21.jpg)
Temperature extremes during product storage (freeze–thaw conditioning)
must not occur.
Supersaturation favours the formation of needle like crystals and should be
avoided.
Rapid or shock cooling and high agitation favour the formation of thin,
small crystals and should be avoided. Slow crystallization by evaporation
yield compact crystals.
Experimentation with different crystallizing solvents is recommended to
change crystal size and shape.
![Page 22: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/22.jpg)
Impurities and foreign substances during crystallization affect the
reproducibility and aggregation potential of many drug particle systems.
Constant crystallizing conditions are essential. Batch-to-batch variation in
crystal size and shape is often associated with poor control of processing
and crystallization procedures.
![Page 23: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/23.jpg)
CONCLUSION
The knowledge and concept of crystal growth naturally forms the
basis for understanding how the crystals form and various factors which
influence the crystal growth. Such an understanding of crystal growth
studies widely used to describe how to improve physical stability of
pharmaceutical formulations.
![Page 24: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/24.jpg)
REFERENCES
Mullin, J.W. Crystallization; Butterworth-Heinemann Ltd.: Oxford, 2001.
Myerson, A.S. Handbook of Industrial Crystallization; Butterworth- Heinemann Oxford, 2002.
Crystallization Technology Handbook; Mersmann; A., Ed.; Marcel Dekker: New York, 1995.
Zettlemoyer, A.C. Nucleation; Marcel Dekker: New York, 1969.
Perepezko, J.H. Nucleation reactions in under cooled liquids. Mater. Sci. Eng.
1994, 178 (1–2), 105–111.
Perepezko, J.H. Kinetic processes in under cooled melts. Mater. Sci. Eng. A. 1997, 226, 374–382.
![Page 25: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/25.jpg)
Fletcher, N.H. Nucleation by crystalline particles. J. Chem. Phys. 1963, 38, 237.
Carter, P.W.; Ward, M.D. Topographically directed nucleation of organic-crystals on molecular single-crystal substrates. J. Am. Chem. Soc. 1993, 115 (24), 11,521– 11,535.
Rodrı´guez-Hornedo, N.; Murphy, D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J. Pharm. Sci. 1999, 88 (7), 651–660.
Ostwald, W. Studien Uber Die Bildung und Umwandlung Fester Korper Z. Phys. Chem. 1897, 22, 289
![Page 26: Seminar on CRYSTAL GROWTH AND ITS PREVENTION By R.TULASI M.Pharmacy, Ist semester Department of pharmaceutics UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES](https://reader036.vdocuments.mx/reader036/viewer/2022062516/56649e6f5503460f94b6d148/html5/thumbnails/26.jpg)
THANK YOU!